Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH

NCT07187193 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Cytarabine (Ara-C)
DRUG: Thalidomide (100mg)

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences